DLGAP2, DLG associated protein 2, 9228

N. diseases: 22; N. variants: 11
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs17669535
rs17669535
Entrez Id: 9228;286083
Gene Symbol: DLGAP2;LOC286083
DLGAP2;LOC286083
CUI: C1314691
Disease:
Age at menarche 		C 0.800 GeneticVariation GWASCAT Genome-wide association study of age at menarche in African-American women. 23599027 2013
dbSNP: rs17669535
rs17669535
Entrez Id: 9228;286083
Gene Symbol: DLGAP2;LOC286083
DLGAP2;LOC286083
CUI: C1314691
Disease:
Age at menarche 		C 0.800 GeneticVariation GWASDB Genome-wide association study of age at menarche in African-American women. 23599027 2013
dbSNP: rs139288166
rs139288166
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0600139
Disease:
Prostate carcinoma 		0.700 GeneticVariation GWASCAT Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. 31095341 2020
dbSNP: rs2404298
rs2404298
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C1561643
Disease:
Chronic Kidney Diseases 		0.700 GeneticVariation GWASCAT Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. 29885931 2018
dbSNP: rs2404298
rs2404298
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0022661
Disease:
Kidney Failure, Chronic 		0.700 GeneticVariation GWASCAT Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. 29885931 2018
dbSNP: rs10111688
rs10111688
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		T 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs10111688
rs10111688
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs4876094
rs4876094
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs17062789
rs17062789
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0019693
Disease:
HIV Infections 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs17062789
rs17062789
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0373595
Disease:
Creatinine clearance measurement 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs17062791
rs17062791
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0373595
Disease:
Creatinine clearance measurement 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs17062791
rs17062791
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0019693
Disease:
HIV Infections 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs34003842
rs34003842
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0373595
Disease:
Creatinine clearance measurement 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs34003842
rs34003842
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0019693
Disease:
HIV Infections 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs73670671
rs73670671
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0019693
Disease:
HIV Infections 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs73670671
rs73670671
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0373595
Disease:
Creatinine clearance measurement 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204 2015
dbSNP: rs28680850
rs28680850
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0202236
Disease:
Triglycerides measurement 		A 0.700 GeneticVariation GWASCAT Amerindian-specific regions under positive selection harbour new lipid variants in Latinos. 24886709 2014
dbSNP: rs1393703
rs1393703
Entrez Id: 9228
Gene Symbol: DLGAP2
DLGAP2
CUI: C0027404
Disease:
Narcolepsy 		0.700 GeneticVariation GWASDB Genome-wide association database developed in the Japanese Integrated Database Project. 19629137 2009